09:00 | Drug delivery systems for glaucoma: an overview | ZEYEN T | ||||||
09:15 | Enzymatic vitreolysis with ocriplasmin | STALMANS P | ||||||
09:30 | Off-label use: Avastin versus Lucentis | DE ZAEYTIJD J | ||||||
09:45 | The future in treatment of DRP and retinal vein occlusion | VAN CALSTER J | ||||||
10:00 | The future in AMD treatment | LEYS A | ||||||
10:15 | Discussion | |||||||
10:30 | Break | |||||||
11:00 | Off-label use in uveitis treatment: what's available? | DE SCHRYVER I | ||||||
11:15 | The future in uveitis treatment | ZIERHUT M | ||||||
11:30 | Off-label use in glaucoma treatment | STALMANS I | ||||||
11:45 | The future in glaucoma treatment | HONDEGHEM K | ||||||
  | ||||||||
12:20 | Discussion | |||||||
12:30 | End of session |